• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[孕35周及以上新生儿高胆红素血症的预防、检测与管理指南]

[Guidelines for prevention, detection and management of hyperbilirubinaemia in newborns of 35 or more weeks of gestation].

作者信息

Sánchez-Redondo Sánchez-Gabriel María Dolores, Leante Castellanos José Luis, Benavente Fernández Isabel, Pérez Muñuzuri Alejandro, Rite Gracia Segundo, Ruiz Campillo Cesar W, Sanz López Ester, Sánchez Luna Manuel

机构信息

Unidad de Neonatología, Hospital Virgen de la Salud, Complejo Hospitalario de Toledo, Toledo, España.

Hospital General Universitario Santa Lucía, Cartagena, España.

出版信息

An Pediatr (Barc). 2017 Nov;87(5):294.e1-294.e8. doi: 10.1016/j.anpedi.2017.03.006. Epub 2017 May 16.

DOI:10.1016/j.anpedi.2017.03.006
PMID:28526241
Abstract

Hyperbilirubinaemia is one of the most frequent causes of hospital readmission during the first week of life. Its detection is still a big challenge, mainly due to the early discharge from the hospital that can be associated with a delay of the diagnosis. The identification of those newborns at risk of developing significant hyperbilirubinaemia is one of the main priorities in the public health care system. An approach to the management of newborn jaundice is presented in this article, following the recommendations based on the medical evidence and on the opinion of the Standards Committee of the Spanish Society of Neonatology.

摘要

高胆红素血症是出生后第一周内再次入院最常见的原因之一。其检测仍然是一项巨大挑战,主要是因为医院早期出院可能会导致诊断延迟。识别那些有发生显著高胆红素血症风险的新生儿是公共卫生保健系统的主要优先事项之一。本文根据基于医学证据和西班牙新生儿学会标准委员会意见的建议,介绍了一种新生儿黄疸的管理方法。

相似文献

1
[Guidelines for prevention, detection and management of hyperbilirubinaemia in newborns of 35 or more weeks of gestation].[孕35周及以上新生儿高胆红素血症的预防、检测与管理指南]
An Pediatr (Barc). 2017 Nov;87(5):294.e1-294.e8. doi: 10.1016/j.anpedi.2017.03.006. Epub 2017 May 16.
2
Italian guidelines for management and treatment of hyperbilirubinaemia of newborn infants ≥ 35 weeks' gestational age.意大利关于胎龄≥35周新生儿高胆红素血症管理与治疗的指南。
Ital J Pediatr. 2014 Jan 31;40(1):11. doi: 10.1186/1824-7288-40-11.
3
Management of late-preterm and term infants with hyperbilirubinaemia in resource-constrained settings.资源受限环境下晚期早产儿和足月儿高胆红素血症的管理
BMC Pediatr. 2015 Apr 12;15:39. doi: 10.1186/s12887-015-0358-z.
4
Management of hyperbilirubinaemia in pancreatic cancer patients.胰腺癌患者高胆红素血症的管理。
Eur J Cancer. 2018 May;94:26-36. doi: 10.1016/j.ejca.2018.01.078. Epub 2018 Mar 20.
5
Severe hyperbilirubinaemia and kernicterus: more caution is needed in newborn jaundice surveillance.重度高胆红素血症和核黄疸:新生儿黄疸监测需更加谨慎。
Ir Med J. 2009 Jul-Aug;102(7):228-9.
6
[Recommendations for the perinatal management and follow up of late preterm newborns].[晚期早产儿围产期管理及随访建议]
An Pediatr (Barc). 2014 Nov;81(5):327.e1-7. doi: 10.1016/j.anpedi.2014.06.006. Epub 2014 Aug 6.
7
Updated Clinical Practice Guidelines for Management of Hyperbilirubinemia in Infants Born at 35 Weeks or More Gestation.更新版 35 周或以上胎龄新生儿高胆红素血症管理临床实践指南。
Pediatr Ann. 2023 Dec;52(12):e436-e439. doi: 10.3928/19382359-20231016-07. Epub 2023 Dec 1.
8
The Italian Registry of kernicterus and hyperbilirubinaemia.意大利核黄疸与高胆红素血症登记处。
J Matern Fetal Neonatal Med. 2012 Oct;25 Suppl 4:118-20. doi: 10.3109/14767058.2012.714998.
9
[Management of jaundice in the newborn≥35 GW: From screening to follow-up after discharge. Guidelines for clinical practice].[胎龄≥35周新生儿黄疸的管理:从筛查到出院后随访。临床实践指南]
Arch Pediatr. 2017 Feb;24(2):192-203. doi: 10.1016/j.arcped.2016.11.011. Epub 2017 Jan 14.
10
[Criteria for hospital discharge of the healthy term newborn after delivery].[健康足月儿产后出院标准]
An Pediatr (Barc). 2017 May;86(5):289.e1-289.e6. doi: 10.1016/j.anpedi.2016.08.011. Epub 2016 Oct 13.

引用本文的文献

1
Study of the Variability of Transcutaneous Bilirubin Determinations Between Different Ethnic Groups.不同种族间经皮胆红素测定变异性的研究。
Children (Basel). 2025 May 16;12(5):643. doi: 10.3390/children12050643.
2
Neonatal jaundice and associated factors in public hospitals of southern Ethiopia: A multi-center cross-sectional study.埃塞俄比亚南部公立医院的新生儿黄疸及相关因素:一项多中心横断面研究。
Heliyon. 2024 Jan 17;10(2):e24838. doi: 10.1016/j.heliyon.2024.e24838. eCollection 2024 Jan 30.
3
Measurement and clinical usefulness of bilirubin in liver disease.
胆红素在肝脏疾病中的测量及临床应用价值
Adv Lab Med. 2021 Jul 9;2(3):352-372. doi: 10.1515/almed-2021-0047. eCollection 2021 Aug.
4
[Interpretation of "International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn"].《关于静脉注射免疫球蛋白在新生儿 Rh 和 ABO 血型介导的溶血性疾病管理中作用的国际指南解读》
Zhongguo Dang Dai Er Ke Za Zhi. 2022 Nov 15;24(11):1183-1188. doi: 10.7499/j.issn.1008-8830.2205158.
5
Systematic review of global clinical practice guidelines for neonatal hyperbilirubinemia.新生儿高胆红素血症全球临床实践指南的系统评价
BMJ Open. 2021 Jan 19;11(1):e040182. doi: 10.1136/bmjopen-2020-040182.